Findings from a clinical trial on treating hypertension, published in the Journal of the American Medical Association (JAMA), highlight the potential of personalized medicine in cardiovascular care, and in the future, could improve treatment adherence, patient outcomes, and the cost-effectiveness of blood pressure-lowering medication.